New heart valve study aims to improve treatment for narrowed aortic valve
NCT ID NCT06342635
First seen Apr 30, 2026
Summary
This study is testing a new heart valve called Hydra in 50 people with severe aortic stenosis, a condition where the heart's main valve narrows. The goal is to see if the valve is safe and works well for up to one year after a minimally invasive replacement procedure. Researchers will also use CT scans to understand how the valve's shape affects heart rhythm problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC VALVE STENOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Copenhagen University Hospital, Rigshospitalet
RECRUITINGCopenhagen, Denmark
Contact
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.